Its antifibrotic effects are particularly notable, as it inhibits NLRP3-associated inflammation and suppresses the PI3K/AKT/mTOR pathway, thereby reducing fibrotic processes in amiodarone-induced pulmonary fibrosis [192]. The gene discussed is NLRP3; the disease is pulmonary fibrosis.